NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,038,467 | +1906.0% | 1,743,565 | +1837.3% | 0.01% | +1100.0% |
Q2 2023 | $51,768 | +36.1% | 90,000 | +283.4% | 0.00% | – |
Q3 2022 | $38,038 | -15.5% | 23,476 | +100.0% | 0.00% | -100.0% |
Q2 2022 | $45,000 | -18.2% | 11,738 | +14.8% | 0.00% | 0.0% |
Q1 2022 | $55,000 | -86.9% | 10,227 | -47.3% | 0.00% | -87.5% |
Q4 2019 | $419,000 | +65.0% | 19,422 | +171.7% | 0.01% | +14.3% |
Q2 2019 | $254,000 | -8.3% | 7,148 | +57.4% | 0.01% | -30.0% |
Q3 2018 | $277,000 | -86.6% | 4,541 | -76.7% | 0.01% | -93.5% |
Q1 2018 | $2,069,000 | – | 19,473 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |